Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

What is Genetic Engineering?

What is Genetic Engineering?

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer.

Therapeutics and clinical risk management·2021

Same author

Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

Sexual medicine·2021

Same author

Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials.

Neurourology and urodynamics·2020

Same author

The Effects of a Genital Vibratory Stimulation Device on Sexual Function and Genital Sensation.

Female pelvic medicine & reconstructive surgery·2016

Same author

Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

The journal of sexual medicine·2016

Same author

Diabetes attenuates urothelial modulation of detrusor contractility and spontaneous activity.

International journal of urology : official journal of the Japanese Urological Association·2014

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Gene therapy for erectile dysfunction: what is the future?

Arnold Melman¹, Kelvin Davies

¹Department of Urology, Albert Einstein College of Medicine, New York, NY 10461, USA. arnold.melman@einstein.yu.edu

Current Urology Reports

|September 15, 2010

Summary

Gene transfer therapy for erectile dysfunction is safe, advancing to further clinical trials. This review covers the scientific background supporting FDA approval for human gene transfer in nonlethal conditions.

Related Experiment Videos

Last Updated: Jun 8, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Biomedical research
Gene therapy
Urology

Background:

Erectile dysfunction (ED) presents a significant unmet medical need.
Gene transfer offers a novel therapeutic approach for ED.
Previous research paved the way for clinical gene transfer applications.

Purpose of the Study:

To review the scientific foundations enabling human gene transfer trials for ED.
To highlight the regulatory pathway for gene therapy in nonlethal diseases.

Main Methods:

Review of preclinical and clinical data on gene transfer for ED.
Analysis of regulatory considerations for human gene therapy trials.
Synthesis of scientific literature supporting gene therapy development.

Main Results:

Phase 1 safety testing for ED gene transfer is complete.
The therapy demonstrated sufficient safety to progress.
Key components leading to FDA acceptance are identified.

Conclusions:

Gene transfer is a viable therapeutic strategy for erectile dysfunction.
The safety profile supports further clinical investigation.
Regulatory acceptance signifies progress in gene therapy for nonlethal diseases.